Healthcare -
Biotechnology - NASDAQ - US
$ 0.1538
-1.91 %
$ 6.11 M
Market Cap
-0.14
P/E
VIRX - INTEREST INCOME & EXPENSE
Interest Income & Expense VIRX - Viracta Therapeutics, Inc.
3.7 M
LAST VALUE
174.66%
2 YEAR CAGR
26.27%
5 YEAR CAGR
2.42%
10 YEAR CAGR